Partner/Owner since 2003
Founder since 2003
Representative before the EPO

Employment test 11 - 50 employees
Company dna isenbruck bosl horschler llp
operating since 2003
Headquarter in Mannheim and 3 offices
active in Legal Services and IP Consulting

We have observed 171 EP applications Raphael Bösl has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 16, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11845786

CYTOTOXICITY-INDUCING THERAPEUTIC AGENT

IPC classification:
A61P 35/00, C07K 16/28, C07K 16/30, C07K 16/46, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/09, A61K 39/395
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP11850640

TRYPSIN-LIKE SERINE PROTEASE INHIBITORS, THEIR PREPARATION AND USE AS SELECTIVE INHIBITORS OF THE CLOTTING FACTORS IIA AND XA

IPC classification:
A61P 7/06, A61P 9/00, C07D 205/04, C07D 207/16, C07D 211/60, C07D 295/192, C07D 401/12, C07D 403/12, C07D 405/12, C07K 5/06, C07K 5/072, C07K 5/078, A61K 38/05
Applicant:
The Medicines Company (Leipzig) GmbH
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
The patent has been granted
EP12719479

CONSTRUCTS AND METHODS FOR GENERATING INDUCED PLURI POTENT STEM ( IPS) CELLS

IPC classification:
C12N 5/07, C12N 5/10, C12N 15/861
Applicant:
University of Utah Research Foundation - Technology and Venture Commercialization (TVC)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12749985

SUPERHYDROPHOBIC AND OLEOPHOBIC COATINGS WITH LOW VOC BINDER SYSTEMS

IPC classification:
B23B 5/02, B23B 27/04, B23B 27/12, C09D 175/04, C09K 3/18
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12005814

Fluid exchange catheter and process for unblocking a fluid exchange catheter

IPC classification:
A61M 25/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION REFUSED
EP12005830

Fluid exchange catheter

IPC classification:
A61M 25/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION REFUSED
EP12721111

PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY

IPC classification:
A61P 7/06, A61K 31/4965, A61K 31/497
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12722013

PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY

IPC classification:
A61P 7/06, A61K 31/4965, A61K 31/497
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12722012

PYRUVATE KINASE ACTIVATORS FOR USE FOR INCREASING LIFETIME OF THE RED BLOOD CELLS AND TREATING ANEMIA

IPC classification:
A61P 7/06, A61P 43/00, A61K 31/4704, A61K 31/495, A61K 31/496, A61K 31/5025, A61K 31/551, A61K 31/635
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12724632

DISPENSER WITH FILTER DEVICE

IPC classification:
B01D 35/027, G01N 1/31, G01N 35/10
Applicant:
Ventana Medical Systems, Inc.
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12799802

COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR USES AS IDH1 MUTANTS INHIBITORS FOR TREATING CANCERS

IPC classification:
A61P 35/00, C07D 217/26, C07D 413/04, C07D 491/052, C07D 519/00, A61K 31/496
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP12730388

CATHEPSIN-BINDING COMPOUNDS BOUND TO A CARRIER AND THEIR DIAGNOSTIC USE

IPC classification:
A61P 29/00, A61P 35/00, C07D 405/12, C07K 7/02, A61K 9/127, A61K 47/48, A61K 49/00, A61K 49/18
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12812054

NMR METHODS FOR MONITORING BLOOD CLOT FORMATION

IPC classification:
C12Q 1/56
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12741236

IMPROVED METHODS AND COMPOSITIONS FOR MODULATION OF OLFML3 MEDIATED ANGIOGENESIS

IPC classification:
A61P 35/00, C07K 16/18, A61K 39/395
Applicant:
Research Development Foundation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12820719

TREATMENT OF HEART FAILURE AND RELATED CONDITIONS

IPC classification:
A61P 9/00, C07K 14/495, A61K 38/18
Applicant:
Tufts Medical Center, Inc.
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12777328

PYRAZOLOPYRIDAZINES AND METHODS FOR TREATING RETINAL-DEGENERATIVE DISEASES AND HEARING LOSS ASSOCIATED WITH USHER SYNDROME

IPC classification:
C07C 251/86, C07D 487/04, C07D 519/00, A61K 31/40
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP12772695

METHODS AND COMPOSITIONS FOR THE TREATMENT OF PSYCHOTIC DISORDERS THROUGH THE IDENTIFICATION OF THE OLANZAPINE POOR RESPONSE PREDICTOR GENETIC SIGNATURE

IPC classification:
A61P 25/18, C12Q 1/68, A61K 31/495, A61K 31/517, A61K 31/5415, A61K 31/5513, A61K 31/554
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12826213

NOVEL ANTI-DDR1 ANTIBODY HAVING ANTI-TUMOR ACTIVITY

IPC classification:
A61P 35/00, C07K 16/30, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/09, C12P 21/08, A61K 39/395
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12833431

NMR METHODS FOR ENDOTOXIN ANALYSIS

IPC classification:
G01V 3/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12830083

METHODS FOR TAGGING DNA-ENCODED LIBRARIES

IPC classification:
C40B 50/14, C40B 50/16
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12748701

SLIDE TRANSFER DEVICE

IPC classification:
B01L 9/00, G02B 21/34
Applicant:
Ventana Medical Systems, Inc.
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12753456

IMAGING SYSTEMS, CASSETTES, AND METHODS OF USING THE SAME

IPC classification:
G01N 35/04, G02B 21/24, G02B 21/34
Applicant:
Ventana Medical Systems, Inc.
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12769743

ANTI THIRD PARTY CENTRAL MEMORY T CELLS, METHODS OF PRODUCING SAME AND USE OF SAME IN TRANSPLANTATION AND DISEASE TREATMENT

IPC classification:
A61K 39/00
Applicant:
Yeda Research and Development Co. Ltd.
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12758868

ANTI-HER2 VACCINE BASED UPON AAV DERIVED MULTIMERIC STRUCTURES

IPC classification:
C07K 14/005, C07K 14/71, A61K 39/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12835716

USE OF HEMOPEXIN TO SEQUESTER HEMOGLOBIN

IPC classification:
C12N 5/07
Applicant:
Massachusetts General Hospital
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12769023

HEATING DEVICE FOR ROTARY DRUM FREEZE-DRYER

IPC classification:
F26B 3/30, F26B 5/06
Applicant:
Sanofi Pasteur SA
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP12769022

ROTARY DRUM FOR USE IN A VACUUM FREEZE-DRYER

IPC classification:
F26B 5/06
Applicant:
Sanofi Pasteur SA
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP12769021

PROCESS LINE FOR THE PRODUCTION OF FREEZE-DRIED PARTICLES

IPC classification:
F26B 5/06, A61K 9/16
Applicant:
Sanofi Pasteur SA
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP12769026

PROCESS LINE FOR THE PRODUCTION OF FREEZE-DRIED PARTICLES

IPC classification:
F26B 5/06, A61K 9/16
Applicant:
Sanofi Pasteur SA
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP12843467

DEVICE AND METHOD FOR SUSTAINED RELEASE OF THERAPEUTIC AGENT

IPC classification:
A61P 3/00, A61P 9/00, A61P 29/00, A61K 9/16, A61K 9/20
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12844389

CANCER STEM CELL-SPECIFIC MOLECULE

IPC classification:
C12Q 1/68, G01N 33/15, G01N 33/50, G01N 33/574, A61K 39/39, A61K 39/395
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12829642

CANCER STEM CELL ISOLATION

IPC classification:
A61P 35/00, A61P 35/02, A61P 35/04, C07K 16/30, C12N 5/095, C12N 15/09, C12N 15/113, C12Q 1/02, C12Q 1/04, G01N 33/15, G01N 33/53, G01N 33/574, A61K 31/4745, A61K 31/513, A61K 31/7088, A61K 39/395, A61K 48/00
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12846665

ANTIGEN-BINDING MOLECULE HAVING REGULATED CONJUGATION BETWEEN HEAVY-CHAIN AND LIGHT-CHAIN

IPC classification:
C07K 16/46, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/09, C12P 21/02, C12P 21/08, A61K 39/395
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12853451

ARTIFICIAL KNEE JOINT

IPC classification:
A61F 2/38
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12857248

COMPOSITION AND COATING FOR SUPERHYDROPHOBIC PERFORMANCE

IPC classification:
C09D 5/00, C09K 3/18
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP13736185

TRYPTOLINE DERIVATIVES HAVING KINASE INHIBITORY ACTIVITY AND USES THEREOF

IPC classification:
A61K 31/437
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP13735755

BENZHYDROL-PYRAZOLE DERIVATIVES HAVING KINASE INHIBITORY ACTIVITY AND USES THEREOF

IPC classification:
A61K 31/415
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13736137

METHOD FOR MODULATING PLANT ROOT ARCHITECTURE

IPC classification:
C12N 15/29, A01H 3/04, A01P 5/00, A01P 21/00
Applicant:
Australian National University
Applicant:
North Carolina State University - Office of Technology Transfer
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12800001

THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE

IPC classification:
A61P 35/00, C07D 213/85, C07D 401/04, C07D 401/12, C07D 401/14, C07D 405/12, C07D 405/14, C07D 409/14, C07D 413/14, C07D 417/14, C07D 471/04, C07D 487/04, C07D 498/04, A61K 31/44, A61K 31/496
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP13738187

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

IPC classification:
A61P 35/00, C07C 237/22, C07C 271/22, C07C 271/44, A61K 31/16, A61K 31/357, A61K 31/381, A61K 31/40, A61K 31/415, A61K 31/4164, A61K 31/4192, A61K 31/426, A61K 31/435, A61K 31/495
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP14464003

Stable pharmaceutical composition comprising amorphous rosuvastatin calcium

IPC classification:
A61K 9/20, A61K 31/505
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12769025

A PROCESS LINE FOR THE PRODUCTION OF FREEZE-DRIED PARTICLES

IPC classification:
F26B 5/06
Applicant:
Sanofi Pasteur SA
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13738319

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

IPC classification:
A61P 35/00, C07C 237/22, A61K 31/16, A61K 31/38, A61K 31/40, A61K 31/41, A61K 31/495
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP13746177

HYDROPHOBIC SURFACES ON INJECTION MOLDED OR SHAPED ARTICLES

IPC classification:
B32B 3/02
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12861199

PEPTIDE-COMPOUND CYCLIZATION METHOD

IPC classification:
C07K 1/08, C07K 1/113, C12N 15/09, C12P 21/02, C40B 40/10
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP13733752

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

IPC classification:
A61P 35/00, C07D 251/18, C07D 251/26, A61K 31/53
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Agent:
Jones Day
Status:
EXAMINATION IN PROGRESS
EP12814155

STABLE PROTEIN-CONTAINING PREPARATION CONTAINING ARGININAMIDE OR ANALOGOUS COMPOUND THEREOF

IPC classification:
C07K 16/28, C12N 15/09, C12P 21/08, A61K 9/08, A61K 39/395, A61K 47/12, A61K 47/18, A61K 47/22
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13751876

CONTAINERS FOR AGITATION OF LIQUID SAMPLES AND METHODS OF USE THEREOF

IPC classification:
B65D 90/02
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12873112

METHOD FOR DISSOLVING FLAVONOID COMPOUND, CARBON GLYCOSIDE COMPOUND, OR STILBENE COMPOUND AND METHOD FOR PREPARING INJECTION OR POWDER FOR INJECTION

IPC classification:
A61P 1/16, A61P 5/30, A61P 7/02, A61P 9/00, A61P 9/06, A61P 9/10, A61P 29/00, A61P 31/04, A61P 31/12, A61P 35/00, A61P 39/06, A61K 9/08, A61K 9/19, A61K 47/10, A61K 47/22
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12873232

APPLICATION OF GASTRODIN AS SOLUBILIZER AND METHOD FOR PREPARING INJECTION OR POWDER FOR INJECTION

IPC classification:
A61K 9/08, A61K 9/14, A61K 47/22
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP13822828

CRYSTAL FORM OF CABAZITAXEL AND PREPARATION METHOD THEREOF

IPC classification:
A61P 35/00, C07D 305/14, A61K 31/337
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP13779063

COMPOSITIONS AND METHODS FOR DETECTION OF CANDIDA SPECIES

IPC classification:
C12Q 1/68
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12874920

METHOD FOR PREPARING 5,6,4'-TRIHYDROXYFLAVONE-7-0-D-GLUCURONIC ACID

IPC classification:
C07H 17/07
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP13781905

COMPOSITIONS AND METHODS RELATED TO ANTIBODIES THAT NEUTRALIZE COAGULASE ACTIVITY DURING STAPHYLOCOCCUS AUREUS DISEASE

IPC classification:
A61P 31/00, A61P 31/04, A61K 38/17, A61K 39/395
Applicant:
University of Chicago
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13781062

QUINAZOLINEDIONE DERIVATIVE

IPC classification:
A61P 19/04, A61P 29/00, A61P 35/00, A61P 35/04, A61P 43/00, C07D 239/96, C07D 401/06, C07D 403/06, C07D 405/04, C07D 405/12, C07D 487/04, A61K 31/517, A61K 31/5377
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP13720688

METHOD FOR DEVELOPING NATURAL KILLER CELLS FROM STEM CELLS

IPC classification:
C12N 5/0735, C12N 5/0783, A61K 35/14, A61K 35/54
Applicant:
University of Minnesota
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP13782636

BENZAMIDE DERIVATIVE

IPC classification:
A61P 19/04, A61P 29/00, A61P 35/00, A61P 35/02, A61P 43/00, C07C 211/56, C07C 317/32, C07C 317/34, C07C 323/42, C07C 323/46, C07D 205/04, C07D 207/09, C07D 207/12, C07D 207/14, C07D 211/26, A61K 31/166, A61K 31/40, A61K 31/445, A61K 31/495, A61K 31/496
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP13781494

STAPHYLOCOCCAL COAGULASE ANTIGENS AND METHODS OF THEIR USE

IPC classification:
A61P 31/04, C07K 19/00, C12N 15/62, C12N 15/63, A61K 38/43
Applicant:
University of Chicago
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14189654

Methods of organ regeneration

IPC classification:
C12N 5/07
Applicant:
Massachusetts General Hospital
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13785315

BIOAVAILABILITY OF ORAL METHYLNALTREXONE INCREASES WITH A PHOSPHATIDYLCHOLINE-BASED FORMULATION

IPC classification:
A01N 43/42, A61K 31/44
Applicant:
University of Chicago
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13807865

METHODS COMPOSITIONS RELATED TO THE SMCHD1 GENE

IPC classification:
C12N 15/12, C12Q 1/68
Applicant:
Leiden University Medical Center (Leids Universitair Medisch Centrum (LUMC) - Academisch Ziekenhuis Leiden)
Applicant:
University of Washington CoMotion
Applicant:
University of Rochester Medical Center
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13810699

PORTABLE DEVICE FOR NMR BASED ANALYSIS OF RHEOLOGICAL CHANGES IN LIQUID SAMPLES

IPC classification:
G01V 3/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12881905

METHOD FOR PREPARING HIGH PURITY SCUTELLARIN AGLYCONE

IPC classification:
C07D 311/30
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
The patent has been granted
EP14177558

Microwave range

IPC classification:
H05B 6/64
Applicant:
Dongbu Daewoo Electronics Corporation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP13816635

DNA-ENCODED LIBRARIES HAVING ENCODING OLIGONUCLEOTIDE LINKAGES NOT READABLE BY POLYMERASES

IPC classification:
C40B 40/06
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP14177550

Ice bin and method of transferring ice using the same

IPC classification:
F25C 5/04, F25C 5/18
Applicant:
Dongbu Daewoo Electronics Corporation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
The patent has been granted
EP14177557

Refrigerator with a configurable space

IPC classification:
F25D 11/02, F25D 29/00
Applicant:
Dongbu Daewoo Electronics Corporation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14177553

Ice bin and method of crushing ice using the same

IPC classification:
F25C 5/18
Applicant:
Dongbu Daewoo Electronics Corporation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13001977

TREATMENT OF ISCHEMIA USING STEM CELLS

IPC classification:
A61P 9/10, C12N 5/00, C12N 5/074, A61K 9/00, A61K 35/44, A61K 35/50
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13740246

FLUID EXCHANGE CATHETER AND PROCESS FOR UNBLOCKING A FLUID EXCHANGE CATHETER

IPC classification:
A61M 25/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP13829748

EXOSOME-BASED THERAPEUTICS AGAINST NEURODEGENERATIVE DISORDERS

IPC classification:
C12N 15/88, A61K 9/127
Applicant:
University of Chicago
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14832164

PHARMACEUTICAL PREPARATION COMPRISING AMINOPYRAZOLE DERIVATIVE

IPC classification:
A61P 35/00, A61P 43/00, A61K 9/06, A61K 9/14, A61K 9/16, A61K 9/20, A61K 9/48, A61K 31/4184, A61K 47/12, A61K 47/20, A61K 47/32, A61K 47/36, A61K 47/38
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14177219

Cooling apparatus for refrigerator and control method thereof

IPC classification:
F25B 5/00, F25B 47/02, F25D 11/02
Applicant:
Dongbu Daewoo Electronics Corporation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14177014

Refrigerator for preventing and/or reducing condensation and method for controlling same

IPC classification:
F25D 17/06, F25D 21/04
Applicant:
Dongbu Daewoo Electronics Corporation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14177561

Refrigerator

IPC classification:
F25D 23/04, F25D 25/02
Applicant:
Dongbu Daewoo Electronics Corporation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13773563

ATTENUATED CHIKUNGUNYA VIRUS

IPC classification:
C07K 14/005, A61K 39/12
Applicant:
Research Development Foundation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
The patent has been granted
EP13842962

FGFR3 FUSION GENE AND PHARMACEUTICAL DRUG TARGETING SAME

IPC classification:
A61P 35/00, C07K 14/46, C07K 14/71, C07K 16/18, C07K 16/30, C07K 19/00, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/02, C12N 15/09, A61K 31/4184, A61K 31/4439, A61K 31/454, A61K 31/496, A61K 31/5377, A61K 31/713, A61K 45/00, A61K 47/42
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
The patent has been granted
EP13842222

METHOD FOR EVALUATING BLOOD COAGULATION REACTION

IPC classification:
G01N 33/86
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Applicant:
Nara Medical University
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13846787

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

IPC classification:
A61K 31/17, A61K 31/18
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13849295

SYNERGISTIC COMBINATION OF IMMUNOLOGIC INHIBITORS FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/41, A61K 31/4245
Applicant:
University of Chicago
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13801915

BARCODING NUCLEIC ACIDS

IPC classification:
C12Q 1/68
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
The patent has been granted
EP13849803

PYRAZOLOPYRIDAZINES AND METHODS FOR TREATING RETINAL-DEGENERATIVE DISEASES AND HEARING LOSS ASSOCIATED WITH USHER SYNDROME

IPC classification:
C07D 487/04
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13848995

PYRAZOLOPYRIDAZINES AND METHODS FOR TREATING RETINAL-DEGENERATIVE DISEASES AND HEARING LOSS ASSOCIATED WITH USHER SYNDROME

IPC classification:
A61K 31/5025
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13795929

THERAPEUTIC COMPOUNDS AND COMPOSITIONS AND THEIR USE AS PKM2 MODULATORS

IPC classification:
A61P 7/00, A61P 35/00, C07D 205/04, C07D 401/12, C07D 401/14, C07D 405/12, A61K 31/397, A61K 31/4709
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13850898

ANTIBIOTIC METHODS AND COMPOSITIONS FOR BACTERIA INFECTIONS

IPC classification:
A01N 37/18, A01N 43/16, A01N 63/00, A61K 31/497
Applicant:
University of Chicago
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13852797

VIBRATION DAMPING MATERIAL

IPC classification:
C08K 3/04, C08K 5/14, C08L 33/04, C08L 63/00, C08L 93/00, C09K 3/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
The patent has been granted
EP13857585

COMPOUNDS AND THEIR METHODS OF USE

IPC classification:
A61P 35/00, C07D 413/08, C07D 413/14, C07D 417/08, C07D 417/14, A61K 31/4245, A61K 31/433
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13808311

GLUTAMINASE INHIBITORS AND METHOD OF USE

IPC classification:
A61P 35/00, A61P 37/00, C07D 285/12, A61K 31/433
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP14177214

Absorption refrigeration system

IPC classification:
F25B 15/02, F25B 15/06, F25B 29/00
Applicant:
Dongbu Daewoo Electronics Corporation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13860819

METHODS FOR MONITORING TIGHT CLOT FORMATION

IPC classification:
C12Q 1/56, G01N 24/08
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13865627

COMPOSITIONS AND METHODS FOR THE IDENTIFICATION AND ISOLATION OF CELL-MEMBRANE PROTEIN SPECIFIC BINDING MOIETIES

IPC classification:
C04B 20/04, C12N 1/00, C40B 30/04
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12731990

METHOD FOR IMPROVING PHYSICAL PROPERTIES OF ANTIBODY

IPC classification:
A61P 37/06, C07K 16/36, C12P 21/02, C12P 21/08, C12Q 1/02, G01N 33/53, A61K 39/395
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP13898642

FIVE LEVEL INVERTER

IPC classification:
H02M 7/48
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14749616

AUTOMATIC ANALYSIS DEVICE

IPC classification:
G01N 21/76, G01N 27/28, G01N 27/416, G01N 35/08
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14757218

METHODS FOR THE PRODUCTION OF LIBRARIES FOR DIRECTED EVOLUTION

IPC classification:
C40B 10/00, C40B 40/00, C40B 40/06, C40B 50/06
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14754094

METHODS AND DEVICES FOR SKIN TIGHTENING

IPC classification:
A61F 13/02
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14764384

METHODS AND COMPOSITIONS FOR BACTERIA INFECTIONS

IPC classification:
A61P 31/04
Applicant:
University of Chicago
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14775449

COMPOSITIONS AND METHODS FOR DETECTING AND DETERMINING A PROGNOSIS FOR PROSTATE CANCER

IPC classification:
C12Q 1/68
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14774108

GRAFTED POLYETHYLENE

IPC classification:
C08F 4/28, C08F 255/02, C08F 290/06
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14765650

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

IPC classification:
A61P 7/06, A61P 35/02, C07D 401/10, C07D 401/12, C07D 413/10, C07D 413/12, C07D 417/10, C07D 417/12, A61K 31/18, A61K 31/428, A61K 31/4738, A61K 31/473, A61K 31/495
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14765803

NANOLAMINATE COATINGS

IPC classification:
C25D 5/10
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14763369

METHODS AND COMPOSITIONS FOR GENERATING STABLE TRANSFECTED CELLS

IPC classification:
C12N 5/10
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14762282

NICKEL CHROMIUM NANOLAMINATE COATING HAVING HIGH HARDNESS

IPC classification:
C25D 5/14
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14794420

COMPOSITIONS AND METHODS FOR PROMOTING NITRIC OXIDE PRODUCTION THROUGH AN ORAL DELIVERY SYSTEM

IPC classification:
A61K 35/74
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14791060

MICROCLOSURES AND RELATED METHODS FOR SKIN TREATMENT

IPC classification:
A61F 13/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14882792

CENTRALIZED MPPT EXITING AND SWITCHING METHOD AND APPLICATION THEREOF

IPC classification:
H02J 3/38
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION PUBLISHED
EP14768716

IDENTIFICATION AND USE OF CIRCULATING NUCLEIC ACID TUMOR MARKERS

IPC classification:
C12Q 1/68
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14794056

HEART VALVE ASSISTIVE PROSTHESIS

IPC classification:
A61F 2/24
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14819418

PYRROLOQUINOLINE QUINONE LITHIUM SALT CRYSTAL AND PREPARATION METHOD AND APPLICATION THEREOF

IPC classification:
A61P 25/28, C07D 471/04, A61K 31/4745
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14765733

ELECTRODEPOSITED COMPOSITIONS AND NANOLAMINATED ALLOYS FOR ARTICLES PREPARED BY ADDITIVE MANUFACTURING PROCESSES

IPC classification:
C25D 3/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14811138

METHOD FOR PREDICTING POST-THERAPY PROGNOSIS OF RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENT, AND METHOD FOR DETERMINING APPLICABILITY OF NOVEL THERAPY

IPC classification:
A61P 25/00, C12Q 1/06, G01N 33/50, A61K 39/395, A61K 45/00
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP15003342

ELECTRODEPOSITED NANOLAMINATE COATINGS AND CLADDINGS FOR CORROSION PROTECTION

IPC classification:
C25D 5/10, C25D 5/14, C25D 5/18, C25D 5/20, C25D 15/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14822346

AN OPTICAL ELEMENT HAVING TWO PHASE MASKS

IPC classification:
G01J 5/08, G02B 1/00, G02B 5/00, G02B 27/00, G06K 7/14, G06K 19/06
Applicant:
Ramot at Tel-Aviv University Ltd.
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14832195

NANOCHANNELED DEVICE WITH ELECTRODES AND RELATED METHODS

IPC classification:
A61K 9/48, A61M 37/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14836861

DEVICE AND METHOD FOR SUSTAINED RELEASE OF LOW WATER SOLUBILITY THERAPEUTIC AGENT IN SOLUBILIZER

IPC classification:
A61K 9/52, A61M 37/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14849352

METHOD FOR PRODUCING ANTIGEN-BINDING MOLECULE USING MODIFIED HELPER PHAGE

IPC classification:
C12N 7/00, C12N 15/09, C12P 21/08
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP11811286

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

IPC classification:
A61P 35/00, A61K 31/496
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP14839001

ENGINEERED PRIMATE CYSTINE/CYSTEINE DEGRADING ENZYMES AS ANTINEOGENIC AGENTS

IPC classification:
C12N 9/88
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14841459

NMR SENSOR FOR RAPID, NON-INVASIVE DETERMINATION OF HYDRATION STATE OR VASCULAR VOLUME OF A SUBJECT

IPC classification:
G01N 24/08, A61B 5/05
Applicant:
Massachusetts Institute of Technology (MIT) Inc.
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14847194

FLEXIBLE SUPERHYDROPHOBIC AND/OR OLEOPHOBIC POLYURETHANE COATINGS

IPC classification:
C08G 18/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14845187

UNIVERSAL RECHARGEABLE BATTERY CONSTITUTED BY EMPLOYING LITHIUM-ION BATTERY AND CONTROL METHOD

IPC classification:
H01M 10/42, H02J 7/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14847022

IDENTIFICATION OF STRUCTURALLY SIMILAR SMALL MOLECULES THAT ENHANCE THERAPEUTIC EXON SKIPPING

IPC classification:
C12Q 1/68
Applicant:
University of California
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP16164863

FLUID EXCHANGE CATHETER AND PROCESS FOR UNBLOCKING A FLUID EXCHANGE CATHETER

IPC classification:
A61M 25/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14855498

QUINAZOLINONE AND ISOQUINOLINONE DERIVATIVE

IPC classification:
A61P 11/00, A61P 29/00, A61P 35/00, A61P 35/04, C07D 217/24, C07D 239/91, C07D 239/94, C07D 401/06, C07D 401/12, C07D 403/06, A61K 31/472, A61K 31/517, A61K 31/519, A61K 31/5377, A61K 31/553
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP16152308

METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS

IPC classification:
C12Q 1/68, A61K 31/225
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14789753

CORROSION INHIBITING COMPOSITIONS AND METHODS

IPC classification:
C23F 11/08, C23F 11/173, C23F 11/18
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP16163214

PHARMACEUTICAL COMPOSITIONS AND MEDICAL USES OF ENGINEERED HUMAN ARGINASES

IPC classification:
A61P 35/00, C07K 19/00, C12N 9/50, C12N 15/57, C12N 15/62, A61K 38/48
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14860720

GENETIC MARKERS OF ANTIPSYCHOTIC RESPONSE

IPC classification:
A61P 25/18
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP16162975

CRYSTAL FORM OF CABAZITAXEL AND PREPARATION METHOD THEREOF

IPC classification:
A61P 35/00, C07D 305/14, A61K 31/337
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP14861246

DISACCHARIDE INTERMEDIATE AND SYNTHESIS METHOD THEREOF

IPC classification:
C07H 1/00, C07H 3/10, C07H 13/08
Applicant:
Zhejiang Hisun Pharmaceutical Co. Ltd.
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP12703422

ENGINEERED IMMUNOGLOBULIN FC POLYPEPTIDES

IPC classification:
C07K 16/28, C07K 16/32
Applicant:
Research Development Foundation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP14864650

GRAFTED POLYMER COMPOSITIONS

IPC classification:
C08F 290/00, C08F 299/00, C08G 81/00, C08J 3/24, C08L 101/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP11811257

BICYCLIC PKM2 ACTIVATORS

IPC classification:
A61P 35/00, C07D 265/18, C07D 265/36, C07D 413/12, A61K 31/536, A61K 31/538
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11808773

NOVEL N-(4-(AZETIDINE-1-CARBONYL)PHENYL)-(HETERO-)ARYLSULFONAMIDE DERIVATIVES AS PYRUVATE KINASE M2 (PMK2) MODULATORS

IPC classification:
A61P 35/00, C07D 215/36, C07D 401/12, A61K 31/397
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14872252

METHODS AND DEVICES FOR MANIPULATING SUBDERMAL FAT

IPC classification:
A61M 1/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14873761

FGFR GATEKEEPER MUTANT GENE AND DRUG TARGETING SAME

IPC classification:
A61P 35/00, A61P 43/00, A61K 31/4184, A61K 31/496, A61K 31/506, A61K 31/517, A61K 31/519
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14874295

METHOD FOR PURIFYING ANTIBODY HAVING LOW ISOELECTRIC POINT

IPC classification:
C07K 1/18, C07K 1/20, C07K 1/22, C07K 16/00, A61K 39/395
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15187267

REFRIGERATOR AND METHOD FOR MANUFACTURING THE SAME

IPC classification:
F25C 5/00, F25D 21/04
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15187266

DEPTH-ADJUSTABLE ICE COMPARTMENT FOR REFRIGERATOR AND METHOD FOR MANUFACTURING THE SAME

IPC classification:
F25C 5/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15187263

ICE MAKER OF A REFRIGERATOR AND METHOD OF MANUFACTURING THE SAME

IPC classification:
F25C 1/24
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15187265

REFRIGERATOR AND METHOD FOR ASSEMBLING ICE MACHINE THEREOF

IPC classification:
F25C 1/04, F25C 1/24
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15776419

IMMUNOACTIVATING ANTIGEN-BINDING MOLECULE

IPC classification:
A61P 35/00, A61P 43/00, C07K 16/30, A61K 39/395
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15780038

METHODS AND COMPOSITIONS FOR MODIFYING GENOMIC DNA

IPC classification:
C12N 5/10
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15793048

T CELL-REDIRECTED ANTIGEN-BINDING MOLECULE FOR CELLS HAVING IMMUNOSUPPRESSION FUNCTION

IPC classification:
A61P 15/00, A61P 35/00, A61P 35/02, C07K 16/28, C07K 16/46, C12N 15/00, A61K 39/395
Applicant:
Osaka University
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15187261

REFRIGERATOR HAVING LOCKING DEVICE FOR ICE BUCKET AND METHOD FOR INSTALLING LOCKING DEVICE FOR ICE BUCKET

IPC classification:
F25C 5/00, F25C 5/18, F25D 11/02
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP16002068

COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS

IPC classification:
C12N 15/11
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION PUBLISHED
EP15738385

LIQUID FEEDING DEVICE FOR THE GENERATION OF DROPLETS

IPC classification:
B01D 1/18
Applicant:
Sanofi Pasteur SA
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15834988

ADMINISTRATION OF KYNURENINE DEPLETING ENZYMES FOR TUMOR THERAPY

IPC classification:
C12N 9/14, A61K 35/14, A61K 38/46
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15837061

SOLUBLE EPOXIDE HYDROLASE INHIBITORS AND USES THEREOF

IPC classification:
C07D 213/81
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15839768

IDENTIFICATION AND USE OF CIRCULATING NUCLEIC ACIDS

IPC classification:
C12P 19/34, C40B 20/04, C40B 40/06
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP15842179

PREPARATION METHOD FOR AROMATIC HETEROCYCLIC COMPOUND USED AS SELECTIVE JAK3 AND/OR JAK1 KINASE INHIBITOR AND APPLICATION OF AROMATIC HETEROCYCLIC COMPOUND

IPC classification:
A61P 19/10, A61P 35/00, C07D 239/48, C07D 405/12, C07D 413/12, A61K 31/33, A61K 31/506
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP15843023

A METHOD AND APPARATUS FOR CONTINUOUSLY APPLYING NANOLAMINATE METAL COATINGS

IPC classification:
B65G 49/02, C25D 17/28, C25D 21/10
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP15842607

METHODS OF PREPARING ARTICLES BY ELECTRODEPOSITION AND ADDITIVE MANUFACTURING PROCESSES

IPC classification:
B32B 15/04, C25D 5/02, C25D 21/10
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP15842267

NICKEL-CHROMIUM NANOLAMINATE COATING OR CLADDING HAVING HIGH HARDNESS

IPC classification:
C25D 5/02, C25D 5/08, C25D 5/14
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP15845138

COMPOSITIONS AND METHODS FOR ENHANCING HAIR GROWTH, PROMOTING SKIN REGENERATION, AND WOUND HEALING

IPC classification:
A61P 17/02, A61P 17/14, C07C 219/22, A61K 31/245, A61K 31/5575
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP16177331

COMPOSITION COMPRISING POLYSACCHARIDES EXTRACTED FROM LENTINUS, PORIA AND TREMELLA AND USE THEREOF FOR COMBATING INFLUENZA VIRUS

IPC classification:
A61P 31/16, A61K 31/715
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
The application has been published
EP15858273

DEVICES AND METHODS FOR ABLATION OF THE SKIN

IPC classification:
A61B 17/34
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP15864173

PIGMENT EPITHELIUM DERIVED FACTOR (PEDF) FOR THE TREATMENT OF UTERINE FIBROIDS

IPC classification:
A61P 15/00, A61K 38/18
Applicant:
Ramot at Tel-Aviv University Ltd.
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP15864857

METHODS AND COMPOSITIONS FOR TREATING MIGRAINE AND CONDITIONS ASSOCIATED WITH PAIN

IPC classification:
A61P 25/06, C07C 49/786, A61K 9/22
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP15870819

CYTOTOXIC MOLECULES RESPONSIVE TO INTRACELLULAR LIGANDS FOR SELECTIVE T CELL MEDIATED KILLING

IPC classification:
C07K 14/47, C07K 16/26, C07K 19/00, C12N 5/0783, C12N 9/12, C12N 9/50, C12N 9/99, C12N 15/62, C12N 15/86, A61K 35/17
Applicant:
University of California
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP15870818

BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 AND CD20

IPC classification:
C07K 14/705, C07K 16/28, C07K 16/46, C12N 5/0783, C12N 15/62, C12N 15/85, A61K 35/17
Applicant:
University of California
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP17000407

QUINOLINE-8-SULFONAMIDE DERIVATES HAVING AN ANTICANCER ACTIVITY

IPC classification:
A61P 35/00, C07D 215/36, C07D 215/40, C07D 239/42, C07D 241/20, C07D 243/08, C07D 271/12, C07D 277/64, C07D 277/68, C07D 295/192, C07D 319/18, C07D 401/12, C07D 401/14, C07D 403/12, C07D 407/12, C07D 409/12, C07D 417/12, C07D 417/14, A61K 31/497, A61K 31/5513
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
The application has been published
EP15876097

METHODS FOR TAGGING DNA-ENCODED LIBRARIES

IPC classification:
C07H 21/02
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP16705437

SYSTEMS AND METHODS FOR MESO-DISSECTION

IPC classification:
G01N 1/28, G01N 1/38, G01N 33/48, G06T 7/00
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP16703082

SYSTEMS AND METHODS FOR MESO-DISSECTION

IPC classification:
G01N 1/28, G01N 1/38, G01N 33/48, G06T 7/00
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP16742849

LATENT HEAT STORAGE USING RENEWABLE PHASE CHANGE MATERIALS

IPC classification:
C07C 67/02, C07C 67/03, C07C 69/28, C09K 5/06
Applicant:
Trent University
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP16742856

COMPRESSED GAS ENERGY STORAGE SYSTEM

IPC classification:
F02C 6/16, F17C 1/00, F17C 13/00, F25J 1/00, F25J 5/00, F28D 20/00
Applicant:
Trent University
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP16706710

ENGINEERED IMMUNOGLOBULIN FC POLYPEPTIDES DISPLAYING IMPROVED COMPLEMENT ACTIVATION

IPC classification:
C07K 16/00, C07K 16/28, A61K 39/00
Applicant:
Research Development Foundation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP16752850

METHODS OF IDENTIFYING AND VALIDATING AFFINITY REAGENTS

IPC classification:
C12N 15/09, C12Q 1/68, C40B 30/04
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP16756440

METHODS AND APPARATUSES FOR IMPROVING MUTATION ASSESSMENT ACCURACY

IPC classification:
C12Q 1/68
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP15881881

METHODS OF DETERMINING RELATIVE POTENCY OF GLATIRAMER ACETATE AND USE THEREOF IN PREPARING A BATCH OF GLATIRAMER ACETATE AS ACCEPTABLE FOR PHARMACEUTICAL USE

IPC classification:
G01N 33/50, G01N 33/68
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made

Please Sign in to use this feature